Txog Peb - BrightGene Kev noj qab haus huv

Keeb kwm kev loj hlob

2001

BrightGene tau raug tsim tsa.

2006

Tsim cov txheej txheem entecavir synthesis nrog cov cai ywj pheej

2010

Ua tiav Series A nyiaj txiag thiab Lilly Asia Ventures tau los ua tus tswv cuab.
Tsim ib lub koom haum ua lag luam, Xintai Pharmaceuticals.
Tau txais Jiangsu Senran Chemical.
Tau txais Chongqing Qiantai Biology.

2012

Ua tiav Series B nyiaj txiag ntawm 60 lab yuan, coj los ntawm Lilly;
Lub tuam txhab ua lag luam Xintai Pharmaceutical tau tsim

2015

Ua tiav Series C nyiaj txiag ntawm 150 lab yuan, nrog CICC nqis peev; Ua tiav qhov kev sib koom ua ke hloov kho; Xintai
Pharmaceutical dhau qhov tshiab GMP ntawv pov thawj hauv Suav teb

2017

Ua tiav Series D nyiaj txiag, nrog SDIC thiab Huatai nqis peev;
Tau dhau daim ntawv pov thawj ntawm Nyiv PMDA thawj zaug;
Dhau qhov kev tshuaj xyuas ntawm US FDA nrog "zero defect"

2018

Sau npe thiab tsim lub koom haum Hong Kong;
Sau npe thiab tsim lub BrightGene Indonesia grand-subsidiary;
Sau npe thiab tsim lub BrightGene Europe grand-subsidiary;
Peb cov khoom dhau los ntawm EU GMP ntawv pov thawj;
Ua tiav cov nyiaj txiag ntawm 550 lab yuan, nrog Sequoia thiab Horizon nqis peev

2019

Lub Kaum Ib Hlis 8:
Sau npe ntawm STAR Market;
Cov ntsiav tshuaj Entecavir tau pom zoo los ntawm ANDA hauv Tebchaws Meskas;
Fondaparinux Sodium Txhaj Tshuaj tau pom zoo rau npe

2020

Lub hauv paus-ntev ceremony ntawm BrightGene lub hauv paus chaw ua haujlwm thoob ntiaj teb tau ua tiav tiav.
Lub BrightGene Healthcare tau tsim, tsom mus rau R & D thiab kev lag luam los ntawm hluavtaws biology

2021

BrightGene ua cov npe ntawm 50 qhov tseem ceeb ntawm STAR Market nrog nws lub zog;
Oseltamivir Phosphate Capsules (Meishulun®) tau pom zoo rau npe

2023

BrightGene tau teev npe rau saum 100 lub lag luam ntiag tug tshiab hauv Suzhou xyoo 2022;
Kev txhaj tshuaj Argatroban tau pom zoo rau npe;
Oseltamivir Phosphate Qhuav Mix tau pom zoo rau npe

Kaw-loop lag luam Ecosystem

Holypharm + LaurelVenture
Nrhiav lub sijhawm uas tau tsav los ntawm systhetic biology thoob ntiaj teb.

LaurelVenture + BrightGene
Industrial Fund koom nrog hauv qhov project ntxov layout
Nyiaj tshwj xeeb txhawb nqa qhov project incubation thiab yav tom ntej mergers thiab acquisitions

BrightGene Research Institutes
Fermentation Research Institute focusesion strain build and expression synthesis.
Chemical Research lub koom haum tsom rau kev cais cov khoom thiab ua kom huv.

TaiXing, ChongQing, ShanDong, txawv teb chaws chaw
Cov khoom sib txawv raws li cov khoom sib txawv thiab ntsuas kev lag luam ntau lawm.

BrightGene Health
BrightGene Kev Noj Qab Haus Huv ua rau kev txhim kho kev lag luam, lub sijhawm BrightGene muab kev sib koom tes txhawb nqa los ua haujlwm rau cov neeg siv khoom thoob ntiaj teb.

Core R & D Lub Zog

BrightGene Health tsim nyob rau kaum xyoo ntawm kev tshawb fawb microbial thiab kev txhim kho kev ua tiav los ntawm BrightGene Bio-Medical. Ua raws li lub hauv paus ntsiab lus ntawm kev ywj pheej innovation, nws muab qhov tseem ceeb rau kev tshawb fawb thiab kev tsim, tau tsim ib qho chaw ua lag luam hluavtaws biology tshawb fawb thiab kev loj hlob. Lub chaw no tau mob siab rau tsim thiab tsim lub platform tshiab rau kev tshuaj xyuas microbial thiab kev tsim kho, txhawm rau tsav kev loj hlob thiab kev tsim kho tshiab hauv thaj chaw biosynthesis.

Pab neeg: 83 tus neeg R&D, 86% ntawm lawv yog bachelor degree lossis siab dua.

Platform: Tag nrho autonomous chassis cell database; Tag nrho autonomous editing cuab tam rau kev tshuaj ntsuam qauv

Kev them nyiaj yug Kho vajtse: Lub koom haum tshawb fawb muaj thaj tsam ntawm ntau tshaj 5000 m², nrog tus nqi siab tshaj cov cuab yeej tshuaj ntsuam xyuas zoo li NMR, ICP-MS, & 400M NMR

Kev nqis peev: Kev nqis peev R & D tsis tu ncua txhua xyoo, nrog kev nqis peev R&D nce mus txog 180 lab yuan.

Cov npe khoom siv

Certification System thiab Audit Qualifications

page-1600-660

Txoj Cai Kev Txawj Ntse

page-1600-628

Kev lag luam thiab kev tsim kho tshiab

Synthetic Biology Drives Innovative Development hauv Biopharmaceuticals, Kev Kho Tus Kheej, thiab Khoom Noj Khoom Haus.

Pharmaceuticals

Cov neeg nruab nrab; APIs; Kev npaj; Kev sib xyaw tshuaj-dev. Delievery technology platform.

Kev Kho Tus Kheej

Bio-Active Ingredients, Formulations, Enhancing technology.

Khoom noj khoom haus ntxiv

Bio-Active Ingredients, Oral-delievery technology.

Kev lag luam thiab kev tsim kho tshiab

Lub tuam txhab tau nqis peev rau hauv cov kab loj loj fermentation ntau lawm nrog txhua xyoo muaj peev xwm ntawm ntau pua tons ntawm cov khoom xyaw nquag, uas tam sim no ua haujlwm tag nrho. Thawj qhov phiaj xwm los siv txoj kev sib xyaw ua ke tag nrho, tooj liab peptide, tau ua lag luam thiab muab tso rau hauv kev tsim khoom hauv peb lub hlis twg ntawm xyoo 2023, nrog rau tag nrho cov peev txheej txhua xyoo yuav tsum tshaj 2 tons hauv 2024. Lub tuam txhab kuj tau sib sau ua ke ib pab neeg ua haujlwm tsom mus rau lub ntiaj teb no active khoom xyaw ua lag luam. Kev lag luam tau nthuav dav sai, ua tiav kev sib koom tes thiab kev tsim kho channel nrog ntau pua lub npe thoob ntiaj teb.